JP2023528805A5 - - Google Patents
Info
- Publication number
- JP2023528805A5 JP2023528805A5 JP2022573214A JP2022573214A JP2023528805A5 JP 2023528805 A5 JP2023528805 A5 JP 2023528805A5 JP 2022573214 A JP2022573214 A JP 2022573214A JP 2022573214 A JP2022573214 A JP 2022573214A JP 2023528805 A5 JP2023528805 A5 JP 2023528805A5
- Authority
- JP
- Japan
- Prior art keywords
- rna
- puromycin
- polypeptide
- tagged
- library
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026070113A JP2026117232A (ja) | 2020-05-26 | 2026-04-21 | 核酸人工ミニプロテオームライブラリー |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063030056P | 2020-05-26 | 2020-05-26 | |
| US63/030,056 | 2020-05-26 | ||
| PCT/US2021/034131 WO2021242793A2 (en) | 2020-05-26 | 2021-05-26 | Nucleic acid artificial mini-proteome libraries |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026070113A Division JP2026117232A (ja) | 2020-05-26 | 2026-04-21 | 核酸人工ミニプロテオームライブラリー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023528805A JP2023528805A (ja) | 2023-07-06 |
| JP2023528805A5 true JP2023528805A5 (cg-RX-API-DMAC10.html) | 2024-06-04 |
| JP7854946B2 JP7854946B2 (ja) | 2026-05-07 |
Family
ID=76859704
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022573214A Active JP7854946B2 (ja) | 2020-05-26 | 2021-05-26 | 核酸人工ミニプロテオームライブラリー |
| JP2026070113A Pending JP2026117232A (ja) | 2020-05-26 | 2026-04-21 | 核酸人工ミニプロテオームライブラリー |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026070113A Pending JP2026117232A (ja) | 2020-05-26 | 2026-04-21 | 核酸人工ミニプロテオームライブラリー |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230203477A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4158014A2 (cg-RX-API-DMAC10.html) |
| JP (2) | JP7854946B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR20230029673A (cg-RX-API-DMAC10.html) |
| CN (1) | CN116249774A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2021280261A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3185387A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2021242793A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023034901A1 (en) | 2021-09-01 | 2023-03-09 | The Broad Institute, Inc. | Tumor avatar vaccine compositions and uses thereof |
| US12112833B2 (en) | 2020-02-04 | 2024-10-08 | 10X Genomics, Inc. | Systems and methods for index hopping filtering |
| US12168801B1 (en) * | 2020-07-02 | 2024-12-17 | 10X Genomics, Inc. | Hybrid/capture probe designs for full-length cDNA |
| US12580044B1 (en) | 2020-09-02 | 2026-03-17 | 10X Genomics, Inc. | Systems and methods for identifying cells that are antigen-specific for an immunogenic feature |
| US20250144198A1 (en) * | 2021-08-16 | 2025-05-08 | Duke University | Next generation vaccines comprising antigenic libraries and methods of making and using same |
| WO2023076733A1 (en) * | 2021-11-01 | 2023-05-04 | Dana-Farber Cancer Institute, Inc. | Biologically selected nucleic acid artificial mini-proteome libraries |
| EP4594488A1 (en) * | 2022-09-29 | 2025-08-06 | Twist Bioscience Corporation | Libraries for rna enrichment |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3870790A (en) | 1970-01-22 | 1975-03-11 | Forest Laboratories | Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose |
| US4226859A (en) | 1979-06-07 | 1980-10-07 | Velsicol Chemical Corporation | Pyridyl esters of N-alkylidene-substituted phosphor- and phosphonamidic acids |
| ZA825384B (en) | 1981-07-31 | 1983-05-25 | Tillott J B Ltd | Orally administrable pharmaceutical compositions |
| US4369172A (en) | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
| US5364773A (en) | 1991-03-07 | 1994-11-15 | Virogenetics Corporation | Genetically engineered vaccine strain |
| DE3583799D1 (de) | 1985-01-11 | 1991-09-19 | Abbott Lab Ltd | Feste zubereitung mit langsamer freisetzung. |
| CA1341245C (en) | 1988-01-12 | 2001-06-05 | F. Hoffmann-La Roche Ag | Recombinant vaccinia virus mva |
| JP2773959B2 (ja) | 1990-07-10 | 1998-07-09 | 信越化学工業株式会社 | 大腸内放出性固形製剤 |
| EP0575491B1 (en) | 1991-03-07 | 2003-08-13 | Virogenetics Corporation | Genetically engineered vaccine strain |
| US6991797B2 (en) | 1993-07-02 | 2006-01-31 | Statens Serum Institut | M. tuberculosis antigens |
| ES2243937T3 (es) | 1994-04-29 | 2005-12-01 | Baxter Healthcare S.A. | Poxvirus recombinados en regiones esenciales con la ayuda de polinucleotidos extraños. |
| US5705190A (en) | 1995-12-19 | 1998-01-06 | Abbott Laboratories | Controlled release formulation for poorly soluble basic drugs |
| US7255862B1 (en) | 1996-11-14 | 2007-08-14 | Connaught Technology Corporation | ALVAC/FIV constructs |
| WO1999014354A1 (en) | 1997-09-19 | 1999-03-25 | The Trustees Of The University Of The Pennsylvania | Methods and vector constructs useful for production of recombinant aav |
| FR2775601B1 (fr) | 1998-03-03 | 2001-09-21 | Merial Sas | Vaccins vivants recombines et adjuves |
| US6413776B1 (en) | 1998-06-12 | 2002-07-02 | Galapagos Geonomics N.V. | High throughput screening of gene function using adenoviral libraries for functional genomics applications |
| UA73092C2 (uk) | 1998-07-17 | 2005-06-15 | Брістол-Майерс Сквібб Компані | Таблетка з ентеросолюбільним покриттям і спосіб її приготування |
| WO2000006717A2 (en) | 1998-07-27 | 2000-02-10 | Genentech, Inc. | Improved transformation efficiency in phage display through modification of a coat protein |
| EP1101490B1 (en) | 1998-07-28 | 2005-04-13 | Tanabe Seiyaku Co., Ltd. | Preparation capable of releasing drug at target site in intestine |
| CA2334946A1 (en) * | 1998-08-17 | 2000-02-24 | Phylos, Inc. | Methods for producing nucleic acids lacking 3'-untranslated regions and optimizing cellular rna-protein fusion formation |
| US6955808B2 (en) | 1999-09-24 | 2005-10-18 | Uab Research Foundation | Capsid-modified recombinant adenovirus and methods of use |
| US20040170955A1 (en) | 2000-09-08 | 2004-09-02 | Wadih Arap | Human and mouse targeting peptides identified by phage display |
| ES2376454T3 (es) | 2000-12-22 | 2012-03-14 | Grad, Carole, Legal Representative Of Howard, Kaplan | Librer�?as de expresión en fago de fragmentos vh humanos. |
| US7501127B2 (en) | 2002-05-16 | 2009-03-10 | Bavarian Nordic A/S | Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of Modified Vaccinia virus Ankara |
| WO2005035751A1 (ja) * | 2003-10-15 | 2005-04-21 | Keio University | 高機能性タンパク質の迅速、高効率な選択法、それによって得られる高機能性タンパク質、およびその製造方法と利用方法 |
| EP2397490B1 (en) | 2004-07-16 | 2013-09-04 | THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Vaccine constructs and combinations of vaccines designed to improve the breadth of the immune response to diverse strains and clades of HIV |
| EP2573185A3 (en) | 2005-02-16 | 2013-06-05 | Lentigen Corporation | Lentiviral vectors and their use |
| JP2011512326A (ja) | 2007-12-31 | 2011-04-21 | ナノコア セラピューティクス,インコーポレイテッド | 心不全の治療用のrna干渉 |
| US9405700B2 (en) | 2010-11-04 | 2016-08-02 | Sonics, Inc. | Methods and apparatus for virtualization in an integrated circuit |
| LT2714071T (lt) | 2011-05-24 | 2019-10-10 | Biontech Rna Pharmaceuticals Gmbh | Individualizuotos vakcinos nuo vėžio |
| WO2012159643A1 (en) | 2011-05-24 | 2012-11-29 | Biontech Ag | Individualized vaccines for cancer |
| WO2018213803A1 (en) * | 2017-05-19 | 2018-11-22 | Neon Therapeutics, Inc. | Immunogenic neoantigen identification |
| WO2020018461A1 (en) * | 2018-07-16 | 2020-01-23 | The University Of Virginia Patent Foundation | Compositions and methods of diagnosis and treatment for neurological diseases |
-
2021
- 2021-05-26 JP JP2022573214A patent/JP7854946B2/ja active Active
- 2021-05-26 EP EP21740278.3A patent/EP4158014A2/en active Pending
- 2021-05-26 KR KR1020227045521A patent/KR20230029673A/ko active Pending
- 2021-05-26 AU AU2021280261A patent/AU2021280261A1/en active Pending
- 2021-05-26 WO PCT/US2021/034131 patent/WO2021242793A2/en not_active Ceased
- 2021-05-26 CA CA3185387A patent/CA3185387A1/en active Pending
- 2021-05-26 US US17/927,112 patent/US20230203477A1/en active Pending
- 2021-05-26 CN CN202180048206.XA patent/CN116249774A/zh active Pending
-
2026
- 2026-04-21 JP JP2026070113A patent/JP2026117232A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0590689B1 (fr) | Procédé d'obtention d'ADN, ARN, peptides, polypeptides ou protéines, par une technique de recombinaison d'ADN | |
| Tusup et al. | Design of in vitro transcribed mRNA vectors for research and therapy | |
| ATE426022T1 (de) | Prozess, konstrukt und konjugat zur herstellung mehrerer nukleinsaurekopien | |
| JP2000157291A (ja) | 大きな構造遺伝子の製造および発現 | |
| JP2004535163A (ja) | Rnaポリメラーゼから誘導されたポリペプチド及びそれらの使用 | |
| EP3651781A1 (en) | Methods and systems for conditionally regulating gene expression | |
| JP2020510426A5 (cg-RX-API-DMAC10.html) | ||
| HU196237B (en) | Process for producing human growth prehormone | |
| WO2025102442A9 (zh) | 一种基于人源tRNA的自环化RNA | |
| KR20220004060A (ko) | T-세포 수용체 유전자 어셈블리를 위한 조성물 및 방법 | |
| CN115485379A (zh) | 用于体外mRNA转录的合成DNA模板 | |
| JP2023500116A5 (cg-RX-API-DMAC10.html) | ||
| LU82757A1 (fr) | Genes de la proinsuline humaine et de pre-proinsuline humaine,leur procede de preparation et leurs applications | |
| CN111410695B (zh) | 基于自噬机制介导Tau蛋白降解的嵌合分子及其应用 | |
| CN111448320B (zh) | 细胞膜穿透肽 | |
| CA2195090A1 (en) | Lkp pilin structural genes and operon of nontypable haemophilus influenzae | |
| WO2025097031A1 (en) | Compositions and methods for cell therapy | |
| CN117887667A (zh) | 一种用于快速生成car-nk细胞的工程化外泌体的制备方法和应用 | |
| CN117062912A (zh) | 用于基于crispr的转录抑制的融合蛋白 | |
| JP3680392B2 (ja) | マイクロ遺伝子のランダム重合体作成方法 | |
| CN121344095B (zh) | 一种细胞内mRNA传感器开关的DNA文库筛选方法及应用 | |
| WO2025190256A1 (en) | Type ii cas protein and uses thereof | |
| LU103548B1 (en) | Eukaryotic expression plasmid for recombinant porcine macrophage-colony stimulating factor (pm-csf), method of constructing same and use thereof | |
| JP5109040B2 (ja) | ヒト一本鎖抗体遺伝子断片の効率的な新規調製法 | |
| HK40118372A (zh) | 一种通用的制备环状rna的方法及其用途 |